Back
State Street SPDR S&P Pharmaceuticals ETF Stock Price Chart
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Buy
59
XPH
State Street SPDR S&P Pharmaceuticals ETF
Last Price:
$57.26
Seasonality Move:
0.05%
7 Day Trial
ALL ACCESS PASS
$
7
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
State Street SPDR S&P Pharmaceuticals ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.31 | Buy |
| 20-day SMA: | 56.33 | Buy |
| 50-day SMA: | 55.93 | Buy |
| 200-day SMA: | 47.47 | Buy |
| 8-day EMA: | 44.1 | Buy |
| 20-day EMA: | 25.55 | Buy |
| 50-day EMA: | 12.07 | Buy |
| 200-day EMA: | 3.29 | Buy |
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.91 | Buy |
| Relative Strength Index (14 RSI): | 56.07 | Buy |
| Chaikin Money Flow: | 66576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.52 - 56.9) | Buy |
| Bollinger Bands (100): | (48.52 - 56.2) | Buy |
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for State Street SPDR S&P Pharmaceuticals ETF Stock
Is State Street SPDR S&P Pharmaceuticals ETF Stock a Buy?
-
State Street SPDR S&P Pharmaceuticals ETF share price is 57.27 while XPH 8-day simple moving average is 56.31, which is a Buy signal.
-
The stock price of XPH is 57.27 while State Street SPDR S&P Pharmaceuticals ETF 20-day SMA is 56.33, which makes it a Buy.
-
State Street SPDR S&P Pharmaceuticals ETF 50-day simple moving average is 55.93 while XPH share price is 57.27, making it a Buy technically.
-
XPH stock price is 57.27 and State Street SPDR S&P Pharmaceuticals ETF 200-day simple moving average is 47.47, creating a Buy signal.
XPH Technical Analysis vs Fundamental Analysis
Buy
59
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Buy
Is State Street SPDR S&P Pharmaceuticals ETF a Buy or a Sell?
-
State Street SPDR S&P Pharmaceuticals ETF stock is rated a BuyThe current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $57.27. The Score for XPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
State Street SPDR S&P Pharmaceuticals ETF Stock Info
Market Cap:
0
Price in USD:
57.27
Share Volume:
69.4K
State Street SPDR S&P Pharmaceuticals ETF 52-Week Range
52-Week High:
58.00
52-Week Low:
35.22
Buy
59
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Buy
State Street SPDR S&P Pharmaceuticals ETF Share Price Forecast
-
What is the State Street SPDR S&P Pharmaceuticals ETF stock price today?The State Street SPDR S&P Pharmaceuticals ETF stock price is 57.27 USD today.
-
Will XPH stock go up or go down?State Street SPDR S&P Pharmaceuticals ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is State Street SPDR S&P Pharmaceuticals ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, State Street SPDR S&P Pharmaceuticals ETF is not overvalued.
Is State Street SPDR S&P Pharmaceuticals ETF Stock a Buy?
-
State Street SPDR S&P Pharmaceuticals ETF share price is 57.27 while XPH 8-day exponential moving average is 44.10, which is a Buy signal.
-
The stock price of XPH is 57.27 while State Street SPDR S&P Pharmaceuticals ETF 20-day EMA is 25.55, which makes it a Buy.
-
State Street SPDR S&P Pharmaceuticals ETF 50-day exponential moving average is 12.07 while XPH share price is 57.27, making it a Buy technically.
-
XPH stock price is 57.27 and State Street SPDR S&P Pharmaceuticals ETF 200-day simple moving average is 3.29, creating a Buy signal.
Technical Analysis of State Street SPDR S&P Pharmaceuticals ETF
Should I short State Street SPDR S&P Pharmaceuticals ETF stock?
-
XPH Moving Average Covergence Divergence (MACD) indicator is 14.91, suggesting State Street SPDR S&P Pharmaceuticals ETF is a Buy
-
State Street SPDR S&P Pharmaceuticals ETF Relative Strength Index (RSI) is 56.07, which suggest State Street SPDR S&P Pharmaceuticals ETF is overbought
-
The Bollinger Bands (25) for State Street SPDR S&P Pharmaceuticals ETF is (55.52 - 56.9), which suggest State Street SPDR S&P Pharmaceuticals ETF is a Buy
-
The Bollinger Bands (100) for State Street SPDR S&P Pharmaceuticals ETF is (48.52 - 56.2), which suggest State Street SPDR S&P Pharmaceuticals ETF is a Buy
* State Street SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.